G

Genincode PLC
LSE:GENI

Watchlist Manager
Genincode PLC
LSE:GENI
Watchlist
Price: 2.85 GBX -5% Market Closed
Market Cap: 8.2m GBX

Wall Street
Price Targets

GENI Price Targets Summary
Genincode PLC

Wall Street analysts forecast GENI stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for GENI is 11.73 GBX with a low forecast of 11.62 GBX and a high forecast of 12.08 GBX.

Lowest
Price Target
11.62 GBX
308% Upside
Average
Price Target
11.73 GBX
312% Upside
Highest
Price Target
12.08 GBX
324% Upside
Genincode PLC Competitors:
Price Targets
ATRY
Atrys Health SA
115% Upside
2522
Jiangxi Rimag Group Co Ltd
443% Upside
GH
Guardant Health Inc
2% Downside
CSTL
Castle Biosciences Inc
1% Upside
6197
Solasto Corp
17% Downside
PRVA
Privia Health Group Inc
32% Upside
LFST
Lifestance Health Group Inc
30% Upside
HIMS
Hims & Hers Health Inc
25% Upside

Revenue
Forecast

Revenue Estimate
Genincode PLC

For the last 3 years the compound annual growth rate for Genincode PLC's revenue is 33%. The projected CAGR for the next 2 years is 225%.

33%
Past Growth
225%
Estimated Growth
Estimates Accuracy
-4%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Genincode PLC

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
0%
Average Miss

Net Income
Forecast

Net Income Estimate
Genincode PLC

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-68%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is GENI's stock price target?
Price Target
11.73 GBX

According to Wall Street analysts, the average 1-year price target for GENI is 11.73 GBX with a low forecast of 11.62 GBX and a high forecast of 12.08 GBX.

What is Genincode PLC's Revenue forecast?
Projected CAGR
225%

For the last 3 years the compound annual growth rate for Genincode PLC's revenue is 33%. The projected CAGR for the next 2 years is 225%.

Back to Top